FebriDX Point of Contact Rapid Test Device

Graft Gen X Becomes First Tier 2 Distributor of FDA CLIA-Waived FebriDx®

❋ Immediate diagnostic insights during patient visits 
❋ Faster and more accurate treatment decisions
❋ Improved access to quality care in underserved and rural communities
❋ Reduction in unnecessary antibiotic prescriptions
❋ Enhanced clinical efficiency and patient outcomes

  • FebriDx changes the timeline of care. What used to take days now takes minutes. That means faster decisions, better outcomes, and a complete shift in how clinics can treat patients in real time.

  • "Even as a total beginner, I never felt lost. The step-by-step structure and encouragement along the way made all the difference."

    Former Customer

  • "This has been such a worthwhile investment in myself."

    Former Customer